Search results
Found 210 matches for
The COVID-19 International Modelling Consortium (CoMo Consortium) was created by researchers at the University of Oxford and Cornell University, is partnering with infectious disease modellers and public health experts from over 40 countries in Africa, Asia and America. The CoMo Consortium uses a participatory approach to provide decision-making support to policymakers, using evidence from epidemiological and economic models adapted to each country’s context.
PRINCIPLE trial finds antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19
Coronavirus COVID-19 General Research
25 January 2021
In March 2020, the UK-wide Platform Randomised trial of INterventions against COVID-19 In older people (PRINCIPLE) trial was established as a flexible, platform randomised clinical trial to test a range of potential treatments for COVID-19 that might be suitable for use in the community to help people recover more quickly and prevent the need for hospital admission. The trial is one of three national platform trials for COVID-19 treatments, and complements the RECOVERY and REMAP-CAP trials that focus on hospitalised patients.
Early animal studies yield promising results for new potential COVID-19 vaccine
Coronavirus COVID-19 General Research
25 January 2021
Studies carried out in the MRC Human Immunology Unit (MRC HIU) in collaboration with the Pirbright Institute have shown that a new potential vaccine against COVID-19, named RBD-SpyVLP, produces a strong antibody response in mice and pigs, providing vital information for the further development of the vaccine. Although this type of vaccine is not a competitor for the first wave of vaccines, it is hoped that it will be useful as a standalone vaccine or as a booster for individuals primed with a different COVID-19 vaccine.
Just over half of British Indians would take COVID vaccine
Coronavirus COVID-19 General Research
21 January 2021
University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.
Joggers and cyclists should wear masks – here’s why
Coronavirus COVID-19 General Research
19 January 2021
Parental mental health worsens under new national COVID-19 restrictions
Coronavirus COVID-19 General Research
19 January 2021
Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.
RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19
Clinical Trials Coronavirus COVID-19 General Research
18 January 2021
The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19.
National consortium to study threats of new SARS-CoV-2 variants
Coronavirus COVID-19 General Research
18 January 2021
A new national research project to study the effects of emerging mutations in SARS-CoV-2 will be launched with £2.5 million funding from UK Research and Innovation (UKRI).
Oxford scientists: how we developed our COVID-19 vaccine in record time
Coronavirus COVID-19 General Research
13 January 2021
Oxford study confirms medium-term impact of COVID-19
Coronavirus COVID-19 General Research
11 January 2021
A study looking at the longer-term impact of COVID-19 has found that a significant proportion of COVID-19 patients discharged from hospital reported symptoms of breathlessness, fatigue and depression and had limited exercise capacity several weeks after leaving hospital.
Oxford’s researchers on the frontline
Coronavirus COVID-19 General
7 January 2021
We rightly hear a lot about Oxford’s vaccine, Covid-19 research and RECOVERY drug trials, but there are also countless personal stories, which display just how broad Oxford’s response to the pandemic has been. It is the contribution and commitment of many individuals that has enabled Oxford’s Medical Sciences Division to become a global leader.
Oxford vaccine researchers talk research and home-schooling on ITV's This Morning
Coronavirus COVID-19 General Research
7 January 2021
Professor Katie Ewer (The Jenner Institute) and Dr Maheshi Ramasamy (Oxford Vaccine Group) appeared on ITV's This Morning on Wednesday 6 January to talk about their work developing the ChAdOx1 nCoV-19 coronavirus vaccine, all while juggling the demands of young families and home-schooling.
UK National Health Service begins rollout of Oxford coronavirus vaccine
Coronavirus COVID-19 General
4 January 2021
At 7.30 am today, dialysis patient Brian Pinker became the very first person to be vaccinated as part of the UK’s rollout of the Oxford / AstraZeneca coronavirus vaccine, ChAdOx1 nCoV-19, with patients at the Oxford University NHS Hospitals Trust becoming the first to receive this life-saving vaccine.
Oxford University welcomes UK regulatory emergency use authorisation of coronavirus vaccine
Clinical Trials Coronavirus COVID-19 General Research
30 December 2020
The University of Oxford welcomes the news that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK.
Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research
Coronavirus COVID-19 General Research
18 December 2020
In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.
Oxford academics team up with charity to help disadvantaged babies & toddlers
Coronavirus COVID-19 General
17 December 2020
Developmental psychologists at University of Oxford and Oxford Brookes University have raised enough money to provide outdoor baby and toddler weather gear for 70 local families. The rain-sets, provided at discount by Wet Wednesdays, have been distributed by volunteers from Home-Start Oxford to disadvantaged families struggling this winter.
Oxford vaccine stimulates broad antibody and T cell functions
Clinical Trials Coronavirus COVID-19 Research
17 December 2020
Today, researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing the decision to move to a two-dose regimen in ongoing phase III trials, and how ChAdOx1 nCov-19 induces broad antibody and T cell functions.
COVID-19 vaccine hesitancy in the UK
Coronavirus COVID-19 General
14 December 2020
The pandemic is testing our societal structures like never before. To deal with it successfully, we need to think and act collectively, led by our key institutions. But at a time when unity is critical, are we about to see the effects of a long-standing and corrosive drip feed of mistrust?
Cochrane ENT awarded NIHR funding for COVID-19 project
Coronavirus COVID-19 General Research
11 December 2020
Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.
National COVID-19 Infections Survey reveals changes to pandemic over time
Coronavirus COVID-19 General Research
11 December 2020
Data from the National COVID-19 Infection Survey, done in partnership between the University of Oxford, the Office of National Statistics, Public Health England, University of Manchester and the Wellcome Trust, has revealed detailed characteristics of England’s coronavirus pandemic, including which factors have contributed most to case numbers over different phases and the prevalence of asymptomatic infections.